Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated Operating Income
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | ($154.8M) | ($149.9M) | ($229.0M) | ($419.8M) | ($462.7M) | ($613.4M) | ($696.1M) | $113.8M | $2,332.0K | ($903.4M) | ($692.4M) | ($468.7M) | $9,936.0K | $123.2M | $635.2M | $1,197.6M | $2,856.3M | $2,782.1M | $4,307.4M | $4,307.5M |
Vertex Pharmaceuticals Incorporated (VRTX) Operating Income comparison analysis
VRTX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Vertex Pharmaceuticals Incorporated's Operating Income?
As of today, Vertex Pharmaceuticals Incorporated's last 12-month Operating Income is ($314.0M), based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Vertex Pharmaceuticals Incorporated's Operating Income growth rate?
Over the last year, Vertex Pharmaceuticals Incorporated's Operating Income growth was N/A. The average annual Operating Income growth rates for Vertex Pharmaceuticals Incorporated have been N/A over the past three years, N/A over the past five years.